Submit an abstract for the ASH® Meeting on Lymphoma Biology. The deadline to submit is April 29, 2014, at 11:59 p.m. PDT.
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research
A new site design was launched in April, as part of a multi-year effort to upgrade the Society’s technology platforms.
The abstract submission site is now open for the ASH Meeting on Lymphoma Biology. The deadline to submit abstracts is April 29, 2014, 11:59 p.m. (PDT).
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research.
Search a database of practicing hematologists in your area.
Help move hematology forward by supporting research, career development, and quality care and education programs.
Become part of a global network of more than 16,000 hematologists working to conquer blood diseases.
The National Institutes of Health (NIH) yesterday announced that its resubmission policy has changed. Effectively immediately, researchers whose grant applications are unsuccessful may submit the same idea as a new and unassociated application for the next appropriate due date.
Following its April 8 meeting in Washington, DC, the ASH Committee on Government Affairs visited nearly 40 congressional offices on April 9 to explain to Members of Congress and their staff the impact that cuts in funding to the National Institutes of Health (NIH) has on research to find cures and treatments for patients with serious hematologic diseases and the need to continue to support and invest in federal biomedical research funding.
The National Collegiate Athletic Association (NCAA) Sport Science Institute and ASH have coauthored an article on the health, safety, and well-being of student-athletes with sickle cell trait.
On March 31, the U.S. Senate passed a bill that would avert the more than 20 percent cut to Medicare physician payments mandated by the Sustainable Growth Rate (SGR) formula on April 1, 2014.
The American Society of Hematology (ASH) took a meaningful step toward helping facilitate more effective and patient-centered communication between primary care doctors and hematologists through a contribution to a new American College of Physicians (ACP) resource. ASH, the world’s largest professional society concerned with the causes and treatment of blood disorders, contributed several products to ACP’s High Value Care Coordination Toolkit released today and developed collaboratively through ACP’s Council of Subspecialty Societies (CSS) and patient advocacy groups.
the Centers for Medicare & Medicaid Services released a large and complex
set of data about the number and type of health-care services that individual
physicians and certain other health-care professionals delivered in 2012, and
the amount Medicare paid them for those services. The data, which cover $77 billion
of Medicare Part B Fee-for-Service program payments to 880,000 providers, are intended
to allow the public to identify outliers and patterns in payment.
New research published in Blood further illuminates the heart-healthy benefits of the Mediterranean diet, tying the eating plan to lower levels of platelets and white blood cells, two markers of inflammation.
Research published in Blood presents an unprecedented look at five unique blood cells in the human body, pinpointing the location of key genetic regulators in these cells and providing a new tool that may help scientists to identify how blood cells form and shed light on the etiology of blood diseases.
Dr. Lisa Hicks reviews the ASH Choosing Wisely initiative and summarizes the ongoing aims of the ASH Choosing Wisely Task Force.
If you have visited the ASH website in the past few weeks you may have noticed some significant changes. A new site design was launched on April 4, as part of a multi-year effort to upgrade the Society’s technology platforms.
Shurin highlights the National Heart, Lung, and Blood Institute's global health
initiatives, encouraging participation
by hematologists in these programs
through the Global Health Program for
Fellows and Scholars.
Dr. Charles Parker discusses personalized medicine and the importance of developing regulatory and oversight policies and protecting patients' rights.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology